Abstract

Cisplatin is one of the most effective chemotherapeutic agents used in the treatment of malignancies. The clinical use of cisplatin is limited by its severe adverse effects. Acute or long term cardiotoxicity is the most important doselimiting toxicity of cisplatin Cases of angina, myocardial infarction, and atrial arrhythmia have been reported during continuous infusion of cisplatin, but atrioventricular block (AV) has not been reported. Herein, we report a case with recurrent AV block that developed during cisplatin infusion, for the first time.

Highlights

  • Atrioventricular (AV) block can be defined as a delay or interruption in the transmission of an impulse from the atria to the ventricles, and can be transient or permanent

  • Myocardial infarction, and atrial arrhythmia have been reported during continuous infusion of cisplatin, but AV block has not been reported

  • The patient has no history of cardiac disease or disorders, and was not administered cardiovascular medication that changes AV conduction, nearly

Read more

Summary

Introduction

Atrioventricular (AV) block can be defined as a delay or interruption in the transmission of an impulse from the atria to the ventricles, and can be transient or permanent. It has been reported many causes for AV block including drugs, electrolyte disturbances, infiltrative malignancies, hyperthyroidism, and rheumatologic disorders. Myocardial infarction, and atrial arrhythmia have been reported during continuous infusion of cisplatin, but AV block has not been reported.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.